Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risperidone: the search for a better antipsychotic

N L Keltner

    Perspectives in Psychiatric Care
    |January 1, 1995
    PubMed
    Summary

    Risperidone offers an effective treatment for schizophrenia, including refractory cases and negative symptoms. It presents a favorable side-effect profile with fewer extrapyramidal symptoms and potential antidyskinetic properties.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Drugs used for cognitive symptoms of Alzheimer's disease.

    Perspectives in psychiatric care·2004
    Same author

    Nature vs. nurture: two brothers with schizophrenia.

    Perspectives in psychiatric care·2004
    Same author

    Dopaminergic and serotonergic receptor function in the CNS.

    Perspectives in psychiatric care·2004
    Same author

    Adrenergic, cholinergic, GABAergic, and glutaminergic receptor function in the CNS.

    Perspectives in psychiatric care·2004
    Same author

    Atypical antipsychotic drugs: Part II.

    Perspectives in psychiatric care·2002
    Same author

    Mechanisms of antidepressant action: in brief.

    Perspectives in psychiatric care·2002

    Area of Science:

    • Pharmacology
    • Psychiatry
    • Neuroscience

    Background:

    • Schizophrenia treatment remains a significant clinical challenge.
    • Development of novel antipsychotic medications with improved efficacy and tolerability is ongoing.
    • Traditional antipsychotics have limitations in treating negative symptoms and managing extrapyramidal side effects.

    Purpose of the Study:

    • To evaluate the efficacy and tolerability of risperidone as an antipsychotic medication.
    • To assess risperidone's effectiveness in treating both positive and negative symptoms of schizophrenia.
    • To investigate risperidone's side-effect profile, particularly extrapyramidal symptoms (EPSEs) and tardive dyskinesia.

    Main Methods:

    • Clinical trials comparing risperidone to traditional antipsychotics.
    • Assessment of symptom reduction in schizophrenia patients.
    • Monitoring of adverse events, including EPSEs and dyskinetic movements.

    Main Results:

    • Risperidone demonstrates comparable efficacy to traditional antipsychotics in schizophrenia.
    • Evidence suggests risperidone may be more effective for refractory schizophrenia.
    • Risperidone shows significant efficacy in treating negative symptoms of schizophrenia.
    • A superior side-effect profile with reduced EPSEs compared to traditional agents.
    • Potential antidyskinetic properties, possibly improving existing tardive dyskinesia.

    Conclusions:

    • Risperidone is a valuable addition to the antipsychotic treatment armamentarium.
    • Its efficacy in schizophrenia, particularly refractory cases and negative symptoms, is notable.
    • The favorable side-effect profile, including potential antidyskinetic effects, enhances its clinical utility.

    Related Experiment Videos